Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (561-570 of 715) with videos related to

Pageof 72
Sort By:
DNA and Cell Biology|June 1, 1996
Characterization of a helicase-like transcription factor involved in the expression of the human plasminogen activator inhibitor-1 geneH Ding, K Descheemaeker, P Marynen, et al.
Thrombosis and Haemostasis|July 31, 1998
Cloning and characterization of a cDNA encoding murine coagulation factor XZ Liang, A Cooper, M E DeFord, et al.
Thrombosis and Haemostasis|January 1, 1994
Antithrombotic effects and bleeding time prolongation with synthetic platelet GPIIb/IIIa inhibitors in animal models of platelet-mediated thrombosisD Collen, H R Lu, J M Stassen, et al.
Blood|February 15, 1994
Accelerated thrombin generation during anticoagulation in patients with unstable angina pectorisH D Garabedian, H K Gold, J B Newell, et al.
Circulation|January 21, 1997
Recombinant staphylokinase variants with altered immunoreactivity. III: Species variability of antibody binding patternsD Collen, F De Cock, E Demarsin, et al.
Thrombosis Research|February 1, 1992
K1K2Pu, a recombinant t-PA/u-PA chimera with increased thrombolytic potency, consisting of amino acids 1 to 3 and 87 to 274 of human tissue-type plasminogen activator (t-PA) and amino acids 138 to 411 of human single chain urokinase-type plasminogen activator (scu-PA). Purification in centigram quantities and conditioning for use in manD Collen, L Nelles, F De Cock, et al.
Neuroscience|August 17, 2002
Rapid, specific and active site-catalyzed effect of tissue-plasminogen activator on hippocampus-dependent learning in miceR Pawlak, N Nagai, T Urano, et al.
Circulation|November 1, 1995
Effects of disruption of the plasminogen gene on thrombosis, growth, and health in miceV A Ploplis, P Carmeliet, S Vazirzadeh, et al.
Metabolism: Clinical and Experimental|March 1, 1986
Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjectsP Vague, I Juhan-Vague, M F Aillaud, et al.
The Journal of Biological Chemistry|March 31, 1995
Retinoic acid induction of human tissue-type plasminogen activator gene expression via a direct repeat element (DR5) located at -7 kilobasesF Bulens, I Ibañez-Tallon, P Van Acker, et al.
Pageof 72

Showing results (561-570 of 715) with videos related to

Sort By:
Pageof 72
DNA and Cell Biology|June 1, 1996
Characterization of a helicase-like transcription factor involved in the expression of the human plasminogen activator inhibitor-1 geneH Ding, K Descheemaeker, P Marynen, et al.
Thrombosis and Haemostasis|July 31, 1998
Cloning and characterization of a cDNA encoding murine coagulation factor XZ Liang, A Cooper, M E DeFord, et al.
Thrombosis and Haemostasis|January 1, 1994
Antithrombotic effects and bleeding time prolongation with synthetic platelet GPIIb/IIIa inhibitors in animal models of platelet-mediated thrombosisD Collen, H R Lu, J M Stassen, et al.
Blood|February 15, 1994
Accelerated thrombin generation during anticoagulation in patients with unstable angina pectorisH D Garabedian, H K Gold, J B Newell, et al.
Circulation|January 21, 1997
Recombinant staphylokinase variants with altered immunoreactivity. III: Species variability of antibody binding patternsD Collen, F De Cock, E Demarsin, et al.
Thrombosis Research|February 1, 1992
K1K2Pu, a recombinant t-PA/u-PA chimera with increased thrombolytic potency, consisting of amino acids 1 to 3 and 87 to 274 of human tissue-type plasminogen activator (t-PA) and amino acids 138 to 411 of human single chain urokinase-type plasminogen activator (scu-PA). Purification in centigram quantities and conditioning for use in manD Collen, L Nelles, F De Cock, et al.
Neuroscience|August 17, 2002
Rapid, specific and active site-catalyzed effect of tissue-plasminogen activator on hippocampus-dependent learning in miceR Pawlak, N Nagai, T Urano, et al.
Circulation|November 1, 1995
Effects of disruption of the plasminogen gene on thrombosis, growth, and health in miceV A Ploplis, P Carmeliet, S Vazirzadeh, et al.
Metabolism: Clinical and Experimental|March 1, 1986
Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjectsP Vague, I Juhan-Vague, M F Aillaud, et al.
The Journal of Biological Chemistry|March 31, 1995
Retinoic acid induction of human tissue-type plasminogen activator gene expression via a direct repeat element (DR5) located at -7 kilobasesF Bulens, I Ibañez-Tallon, P Van Acker, et al.
Pageof 72